IMABEQ Trademark

Trademark Overview

On Monday, July 5, 2010, a trademark application was filed for IMABEQ with the United States Patent and Trademark Office. The USPTO has given the IMABEQ trademark a serial number of 79085847. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, July 17, 2019. This trademark is owned by Merck KGaA. The IMABEQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of cancer
imabeq

General Information

Serial Number79085847
Word MarkIMABEQ
Filing DateMonday, July 5, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, July 17, 2019
Registration Number3927986
Registration DateTuesday, March 8, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address64293 Darmstadt
DE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address64293 Darmstadt
DE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address64293 Darmstadt
DE

Trademark Events

Event DateEvent Description
Friday, February 7, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, February 7, 2020DEATH OF INTERNATIONAL REGISTRATION
Friday, September 14, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, June 20, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, June 20, 2018INVALIDATION PROCESSED
Thursday, June 14, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 13, 2017CANCELLED SECTION 71
Sunday, February 24, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 8, 2011FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 8, 2011FINAL DISPOSITION PROCESSED
Wednesday, June 8, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 8, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, December 21, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2010PUBLISHED FOR OPPOSITION
Thursday, November 18, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 18, 2010ASSIGNED TO LIE
Tuesday, November 9, 2010REFUSAL PROCESSED BY IB
Wednesday, November 3, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 22, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 22, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 22, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 22, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 19, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 19, 2010REFUSAL PROCESSED BY MPU
Tuesday, October 19, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 18, 2010NON-FINAL ACTION WRITTEN
Monday, October 11, 2010ASSIGNED TO EXAMINER
Tuesday, September 7, 2010APPLICATION FILING RECEIPT MAILED
Friday, September 3, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 2, 2010SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

imabeq treatment cancer prevention human preparations pharmaceutical